GALLIUM CITRATE GA-67 (MALLINCKRODT NUCLEAR MEDICINE LLC)


Welcome to the PulseAid listing for the GALLIUM CITRATE GA-67 drug offered from MALLINCKRODT NUCLEAR MEDICINE LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: MALLINCKRODT NUCLEAR MEDICINE LLC
NON-PROPRIETARY NAME: gallium citrate ga-67
SUBSTANCE NAME: GALLIUM CHLORIDE GA-67
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-02-21
END MARKETING DATE: 0000-00-00


GALLIUM CITRATE GA-67 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGALLIUM CITRATE GA-67 from MALLINCKRODT NUCLEAR MEDICINE LLC
LABELER NAME: MALLINCKRODT NUCLEAR MEDICINE LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mCi/mL)
START MARKETING DATE: 2008-02-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69945-180_75bc49b1-a7ef-4937-b5ec-180d4e9fc954
PRODUCT NDC: 69945-180
APPLICATION NUMBER: NDA018058

Other GALLIUM CHLORIDE GA-67 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
MALLINCKRODT NUCLEAR MEDICINE LLCGALLIUM CITRATE GA-67